Ftse Mib
34.819,74
-1,64%
DAX
18.768,96
0,33%
S&P 500
5.308,13
0,09%
NASDAQ
16.794,87
0,65%
Bitcoin
69.563,09
4,96%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Anchiano Therapeutics Ltd (ANCN) Anchiano Therapeutics Ltd (ANCN) Notizie

ANCN

Anchiano Therapeutics (ANCN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ANCN
DataOraFonteTitoloSimboloCompagnia
16/06/202322:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
19/05/202322:07Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
11/05/202312:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ANCNAnchiano Therapeutics Ltd
23/03/202312:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANCNAnchiano Therapeutics Ltd
29/11/202212:17Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/11/202222:04Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/08/202222:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ANCNAnchiano Therapeutics Ltd
31/05/202216:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ANCNAnchiano Therapeutics Ltd
28/04/202222:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ANCNAnchiano Therapeutics Ltd
25/04/202222:20Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ANCNAnchiano Therapeutics Ltd
03/09/202122:05Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ANCNAnchiano Therapeutics Ltd
18/05/202112:08Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ANCNAnchiano Therapeutics Ltd
29/04/202112:23Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/04/202123:28Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/04/202122:04Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ANCNAnchiano Therapeutics Ltd
30/03/202113:49Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ANCNAnchiano Therapeutics Ltd
26/03/202121:07Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:ANCNAnchiano Therapeutics Ltd
26/03/202113:10Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/03/202122:54GlobeNewswire Inc.Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private FinancingNASDAQ:ANCNAnchiano Therapeutics Ltd
09/03/202122:28Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
09/03/202119:01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:ANCNAnchiano Therapeutics Ltd
10/02/202119:20Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
13/01/202115:32Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:ANCNAnchiano Therapeutics Ltd
15/12/202015:00GlobeNewswire Inc.Anchiano Therapeutics and Chemomab Announce Entry Into Definitive Merger AgreementNASDAQ:ANCNAnchiano Therapeutics Ltd
21/11/201923:01Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:ANCNAnchiano Therapeutics Ltd
18/11/201912:43Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
24/04/201923:22Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)NASDAQ:ANCNAnchiano Therapeutics Ltd
25/03/201921:18Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:ANCNAnchiano Therapeutics Ltd
14/03/201913:16GlobeNewswire Inc.Anchiano Therapeutics Initiates Process to Voluntarily Delist its Ordinary Shares from the Tel Aviv Stock ExchangeNASDAQ:ANCNAnchiano Therapeutics Ltd
13/02/201914:21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:ANCNAnchiano Therapeutics Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ANCN

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BPE
Bper Banca
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENI
Eni
BIT
TIT
Telecom Italia
BIT
BPSO
Banca Popolare di Sondrio
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
SPM
Saipem
BIT
G
Generali
BIT
BAMI
Banco BPM
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
TEN
Tenaris
BIT
TITR
Telecom Italia
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network